Andrew Eland
Direktor/Vorstandsmitglied bei Genomics England Ltd.
Ursprung des Netzwerks ersten Grades von Andrew Eland
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Imperial College London
132
| College/University | Other Consumer Services | 132 |
Genomics England Ltd.
Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom.
14
| Subsidiary | Miscellaneous Commercial Services | 14 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Andrew Eland
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
University of Cambridge | College/University | Graduate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree | |
London Business School | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree Masters Business Admin | |
INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
University of Oxford | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
GSK PLC | Pharmaceuticals: Major | Chief Executive Officer Chairman Corporate Officer/Principal | |
City University London | College/University | Doctorate Degree Graduate Degree | |
Massachusetts Institute of Technology | College/University | Masters Business Admin Graduate Degree | |
Brunel University | College/University | Corporate Officer/Principal Doctorate Degree | |
MedCity Ltd. | Chairman Director/Board Member | ||
Supersolid Ltd.
Supersolid Ltd. Packaged SoftwareTechnology Services Supersolid Ltd. engages in the design and development of mobile and social games. Its flagship products include Adventure Town and Super Penguins. The company was founded by Edward Chin, Kenneth Fejer, Tommy Chuang and Michelle Chuang in 2012 and is headquartered in London, the United Kingdom. | Packaged Software | Founder Founder | |
Nanyang Technological University | College/University | Graduate Degree Undergraduate Degree | |
Royal College of Art | College/University | Graduate Degree Graduate Degree | |
King's College London | College/University | Undergraduate Degree Graduate Degree | |
SENSYNE HEALTH PLC | Miscellaneous Commercial Services | Chairman Chairman | |
Goldman Sachs Asset Management International
Goldman Sachs Asset Management International Investment ManagersFinance Goldman Sachs Asset Management International (GSAMI) is the wholly-owned, Great Britain-based asset management subsidiary of Goldman Sachs Asset Management International Holdings Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm is headquartered in London and was founded in 1990. GSAMI is the hub of Goldman Sachs' European activities, which include investment banking, trading, asset management and securities services. Their clients include individuals, families and family entities, banks and thrift institutions, pooled investment vehicles, pension and profit-sharing plans, trusts, estates, charitable organizations, insurance companies, corporations, and other business entities. | Investment Managers | Market Strategist Portfolio Manager-Equities | |
University of London | College/University | Doctorate Degree Doctorate Degree | |
IMMUNOCORE HOLDINGS PLC | Biotechnology | Chairman Chief Executive Officer | |
Office for Strategic Co-ordination of Health Research | Chairman Director/Board Member | ||
House of Lords | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
Cheung Kong Graduate School of Business | College/University | Masters Business Admin | |
CHINA HUIYUAN JUICE GROUP LIMITED | Beverages: Non-Alcoholic | Director/Board Member | |
Sure Wonder Ltd.
Sure Wonder Ltd. Financial ConglomeratesFinance Sure Wonder Ltd. operates as an investment holding company. The company is headquartered in British Virginia islands. | Financial Conglomerates | Director/Board Member | |
AGORA HOSPITALITY GROUP CO., LTD | Hotels/Resorts/Cruise lines | Director/Board Member | |
King Terrace Ltd.
King Terrace Ltd. Financial ConglomeratesFinance King Terrace Ltd. operates as an investment holding Chinese company. The private company is based in Hong Kong, Hong Kong. | Financial Conglomerates | Director/Board Member | |
Beautiwin Ltd.
Beautiwin Ltd. Real Estate Investment TrustsFinance Beautiwin Ltd. invests in and develops real estate. The private company is based in Hong Kong, Hong Kong. | Real Estate Investment Trusts | Director/Board Member | |
Sino-Singapore (Chengdu) Innovation Park Development Co., Ltd.
Sino-Singapore (Chengdu) Innovation Park Development Co., Ltd. Real Estate DevelopmentFinance Sino-Singapore (Chengdu) Innovation Park Development Co., Ltd. engages in urban infrastructure and supporting construction projects. It involves in the industrial development, planning, and management of industries such as electronic information, biomedicine, and new economy. The company was founded on June 1, 2012 and is headquartered in Chengdu, China. | Real Estate Development | Director/Board Member | |
HENGAN INTERNATIONAL GROUP COMPANY LIMITED | Household/Personal Care | Chief Executive Officer | |
Dymon Asia Capital Pte Ltd
Dymon Asia Capital Pte Ltd Investment ManagersFinance Dymon Asia Capital Pte Ltd (Dymon Asia Capital) is a Private Equity subsidiary of Dymon Asia Capital Ltd founded in 2012. The firm is headquartered in Singapore with additional office in Malaysia and Thailand. | Investment Managers | Private Equity Investor | |
Navis Management Sdn. Bhd.
Navis Management Sdn. Bhd. Investment ManagersFinance Navis Management Sdn. Bhd. (Navis Management) is a private equity firm located in Kuala Lumpur founded in 1998. The firm is headquartered in Malaysia with offices in Thailand, China, India, Australia and Singapore. | Investment Managers | Corporate Officer/Principal | |
SEG INTERNATIONAL | Miscellaneous Commercial Services | Director/Board Member | |
University of Kent | College/University | Undergraduate Degree | |
CapitaLand China Trust Management Ltd.
CapitaLand China Trust Management Ltd. Investment ManagersFinance CapitaLand China Trust Management Ltd. provides investment management services and is ultimately controlled by the Government of Singapore. The company is based in Singapore, Singapore. Tze Wooi Tan has been the CEO of the Singaporean company since 2007. | Investment Managers | Director/Board Member | |
School of Chemical Engineering Ntua | College/University | Undergraduate Degree | |
Blue Earth Diagnostics Ltd.
Blue Earth Diagnostics Ltd. Medical/Nursing ServicesHealth Services Blue Earth Diagnostics Ltd. engages in the development and commercialization of positron emission tomography imaging agents. It focuses on the molecular imaging diagnostics. The company was founded in March 2014 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
ATHENS WATER SUPPLY AND SEWERAGE COMPANY S.A. | Water Utilities | Director/Board Member | |
Hellenic Association of Chemical Engineers | Director/Board Member | ||
Technical Chamber of Greece | Corporate Officer/Principal | ||
Hellenic Horseracing Organization SA | Director/Board Member | ||
CapitaLand Township Pte Ltd.
CapitaLand Township Pte Ltd. Financial ConglomeratesFinance CapitaLand Township Pte Ltd. is a subsidiary of CapitaLand Group, one of Singapore's largest diversified real estate groups. The company is based in Singapore, Singapore and ultimately controlled by the Government of Singapore. The Singaporean company's portfolio includes integrated developments, retail, office, lodging, residential, and new economy sectors such as business parks, industrial, logistics, and data centers. CapitaLand Investment (CLI), headquartered and listed in Singapore, is a leading real estate investment manager with a strong foothold. CLI aims to scale its FUM and fee-related earnings through its full stack of investment management and operating capabilities. As part of the CapitaLand Group, CLI places sustainability at the core of what it does. | Financial Conglomerates | Chief Executive Officer | |
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
CAPITALAND LIMITED | Real Estate Development | Corporate Officer/Principal | |
CAPITALAND CHINA TRUST | Real Estate Investment Trusts | Director/Board Member | |
SPRITZER | Beverages: Non-Alcoholic | Director/Board Member | |
CAPITALAND INVESTMENT LIMITED | Real Estate Investment Trusts | Corporate Officer/Principal | |
Neogene Therapeutics, Inc.
Neogene Therapeutics, Inc. BiotechnologyHealth Technology Neogene Therapeutics, Inc. engages in the provision T cell therapies to treat cancer. The company was founded by Ton N. M. Schumacher and Carsten Linnemann and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
QINQIN FOODSTUFFS GROUP (CAYMAN) COMPANY LIMITED | Food: Specialty/Candy | Chairman | |
Lianjie Investments Group Ltd. | Chief Executive Officer | ||
Quell Therapeutics Ltd.
Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
Vereinigtes Königreich | 23 |
Singapur | 7 |
Griechenland | 6 |
China | 5 |
Malaysia | 5 |
Sektoral
Finance | 16 |
Consumer Services | 15 |
Health Technology | 6 |
Consumer Non-Durables | 5 |
Commercial Services | 3 |
Operativ
Director/Board Member | 306 |
Corporate Officer/Principal | 123 |
Chairman | 77 |
Undergraduate Degree | 62 |
Graduate Degree | 60 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Annalisa Jenkins | 51 |
Siong Kiat Chua | 46 |
Richard Sykes | 37 |
Eliot Forster | 35 |
John Bell | 27 |
Greg Hawkins | 26 |
Jonathan Symonds | 24 |
Jamil Akbar | 22 |
Tze Shyang Puah | 20 |
Ahmet Sener | 17 |
Zulikat Abiola | 16 |
Patrick Verlaine | 15 |
Hector Jeronimo Dominguis Perez | 15 |
Imran Hamid | 14 |
Dido Harding | 13 |
- Börse
- Insiders
- Andrew Eland
- Unternehmensverbindungen